These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 15632380
1. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC. J Natl Cancer Inst; 2005 Jan 05; 97(1):51-9. PubMed ID: 15632380 [Abstract] [Full Text] [Related]
4. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE. Hum Mol Genet; 2003 Oct 15; 12(20):2679-92. PubMed ID: 12944421 [Abstract] [Full Text] [Related]
5. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea. Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY. Clin Cancer Res; 2005 Jul 01; 11(13):4775-8. PubMed ID: 16000574 [Abstract] [Full Text] [Related]
7. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort. Freedman ML, Penney KL, Stram DO, Le Marchand L, Hirschhorn JN, Kolonel LN, Altshuler D, Henderson BE, Haiman CA. Hum Mol Genet; 2004 Oct 15; 13(20):2431-41. PubMed ID: 15317758 [Abstract] [Full Text] [Related]
8. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H. J Natl Cancer Inst; 2005 Apr 06; 97(7):525-32. PubMed ID: 15812078 [Abstract] [Full Text] [Related]
11. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Wang-Gohrke S, Chang-Claude J, Becher H, Kieback DG, Runnebaum IB. Cancer Res; 2000 May 01; 60(9):2348-50. PubMed ID: 10811106 [Abstract] [Full Text] [Related]
12. A role for XRCC4 in age at diagnosis and breast cancer risk. Allen-Brady K, Cannon-Albright LA, Neuhausen SL, Camp NJ. Cancer Epidemiol Biomarkers Prev; 2006 Jul 01; 15(7):1306-10. PubMed ID: 16835328 [Abstract] [Full Text] [Related]
18. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Australian Ovarian Cancer Study Management Group. J Natl Cancer Inst; 2008 Nov 05; 100(21):1519-29. PubMed ID: 18957670 [Abstract] [Full Text] [Related]